Join us for an educational webinar session where we explore the relevance of HER2 expression in invasive breast cancer.

Our presenters, Anna Gasior and Leanne Gough from APIS Assay Technologies, will provide a comprehensive overview of the latest advancements in HER2 expression testing, with a particular emphasis on the emerging concept of HER2-low. 

Webinar Highlights: 

• HER2 as a predictive and prognostic marker in invasive breast cancer 

• HER2 testing methodologies 

• The significance of HER2-low classification 

• Implications for treatment strategies  

Have your questions answered by experts in gene mutation assay development and validation!

Register here: https://attendee.gotowebinar.com/register/3150349743017902679?source=APIS+Website